Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7648)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 28, 2017 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Radiology
ISSN
1949-8470
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bauckneht M, Piva R, Sambuceti G, Grossi F, Morbelli S. Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography? World J Radiol 2017; 9(2): 27-33 [PMID: 28298962 DOI: 10.4329/wjr.v9.i2.27] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v9/i2/27.htm |
| Number | Citing Articles |
| 1 |
Giovanni Rossi, Matteo Bauckneht, Carlo Genova, Erika Rijavec, Federica Biello, Simone Mennella, Maria Giovanna Dal Bello, Giuseppe Cittadini, Paolo Bruzzi, Roberta Piva, Valentina Ceriani, Gianmario Sambuceti, Egesta Lopci, Silvia Morbelli, Francesco Grossi. Comparison Between 18F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab. Journal of Nuclear Medicine 2020; 61(7): 990 doi: 10.2967/jnumed.119.233056
|
| 2 |
Laura Evangelista, Marion de Jong, Silvana del Vecchio, Weibo Cai. The new era of cancer immunotherapy: what can molecular imaging do to help?. Clinical and Translational Imaging 2017; 5(4): 299 doi: 10.1007/s40336-017-0241-z
|
| 3 |
Neal Deot, Amar Suryadevara. Recent developments in head and neck melanoma. Current Opinion in Otolaryngology & Head & Neck Surgery 2020; 28(4): 258 doi: 10.1097/MOO.0000000000000633
|
| 4 |
É. Fréneaux. Évaluation de la réponse thérapeutique après traitement par inhibiteurs des checkpoints (anticorps monoclonaux immunomodulateurs). Médecine Nucléaire 2017; 41(4): 307 doi: 10.1016/j.mednuc.2017.06.005
|
| 5 |
Narjess Ayati, Ramin Sadeghi, Zahra Kiamanesh, Sze Ting Lee, S. Rasoul Zakavi, Andrew M. Scott. The value of 18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging 2021; 48(2): 428 doi: 10.1007/s00259-020-04967-9
|
| 6 |
Silvia Morbelli, Maria Lucia Calcagni, Angelina Cistaro, Mohsen Farsad, Luca Guerra, Cristina Nanni, Andrea Bianchi. The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC). Clinical and Translational Imaging 2020; 8(1): 29 doi: 10.1007/s40336-019-00354-z
|
| 7 |
Jinping Tao, Ziqing Zeng, Chengxue He, Lin Meng, Wenyuan Zhou, Ya’nan Ren, Xiaopan Ma, Zilei Wang, Jiayue Liu, Dapeng Li, Qian Zhang, Chuanke Zhao, Zhi Yang, Hua Zhu. Construction and Preclinical Evaluation of 124I/125I-Labeled Antibody Targeting T Cell Immunoglobulin and Mucin Domain-3. Molecular Pharmaceutics 2024; 21(2): 944 doi: 10.1021/acs.molpharmaceut.3c01046
|
| 8 |
Matteo Bauckneht, Carlo Genova, Giovanni Rossi, Erika Rijavec, Maria Dal Bello, Giulia Ferrarazzo, Marco Tagliamento, Maria Donegani, Federica Biello, Silvia Chiola, Lodovica Zullo, Stefano Raffa, Francesco Lanfranchi, Giuseppe Cittadini, Cecilia Marini, Egesta Lopci, Gianmario Sambuceti, Francesco Grossi, Silvia Morbelli. The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab. Cancers 2021; 13(13): 3117 doi: 10.3390/cancers13133117
|
| 9 |
Áron Roxin, François Bénard. Nuclear Medicine and Immunology. 2022; : 61 doi: 10.1007/978-3-030-81261-4_3
|
| 10 |
Luana Calabrò, Aldo Morra, Robin Cornelissen, Joachim Aerts, Michele Maio. Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challenge. Cancer Immunology, Immunotherapy 2018; 67(8): 1317 doi: 10.1007/s00262-018-2191-3
|
| 11 |
Brett W. Carter, Priya R. Bhosale, Wei T. Yang. Immunotherapy and the role of imaging. Cancer 2018; 124(14): 2906 doi: 10.1002/cncr.31349
|
| 12 |
Bhanusupriya Somarouthu, Susanna I Lee, Trinity Urban, Cheryl A Sadow, Gordon J Harris, Avinash Kambadakone. Immune-related tumour response assessment criteria: a comprehensive review. The British Journal of Radiology 2018; 91(1084): 20170457 doi: 10.1259/bjr.20170457
|
| 13 |
Romain-David Seban, John S. Nemer, Aurélien Marabelle, Randy Yeh, Eric Deutsch, Samy Ammari, Antoine Moya-Plana, Fatima-Zohra Mokrane, Robyn D. Gartrell, Grace Finkel, Luke Barker, Amélie E. Bigorgne, Lawrence H. Schwartz, Yvonne Saenger, Caroline Robert, Laurent Dercle. Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics. European Journal of Nuclear Medicine and Molecular Imaging 2019; 46(11): 2298 doi: 10.1007/s00259-019-04411-7
|
| 14 |
Haley L. Wissler, Emily B. Ehlerding, Zhigang Lyu, Yue Zhao, Si Zhang, Anisa Eshraghi, Zakey Yusuf Buuh, Jeffrey C. McGuth, Yifu Guan, Jonathan W. Engle, Sarah J. Bartlett, Vincent A. Voelz, Weibo Cai, Rongsheng E. Wang. Site-Specific Immuno-PET Tracer to Image PD-L1. Molecular Pharmaceutics 2019; 16(5): 2028 doi: 10.1021/acs.molpharmaceut.9b00010
|
| 15 |
Cinzia Solinas, Michele Porcu, Zuzana Hlavata, Pushpamali De Silva, Marco Puzzoni, Karen Willard-Gallo, Mario Scartozzi, Luca Saba. Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy. Critical Reviews in Oncology/Hematology 2017; 120: 13 doi: 10.1016/j.critrevonc.2017.09.017
|
| 16 |
Carsten S. Kramer, Antonia Dimitrakopoulou-Strauss. Immuno-Imaging (PET/SPECT)–Quo Vadis?. Molecules 2022; 27(10): 3354 doi: 10.3390/molecules27103354
|
| 17 |
Stefan K. Alig, Mohammad Shahrokh Esfahani, Andrea Garofalo, Michael Yu Li, Cédric Rossi, Tim Flerlage, Jamie E. Flerlage, Ragini Adams, Michael S. Binkley, Navika Shukla, Michael C. Jin, Mari Olsen, Adèle Telenius, Jurik A. Mutter, Joseph G. Schroers-Martin, Brian J. Sworder, Shinya Rai, Daniel A. King, Andre Schultz, Jan Bögeholz, Shengqin Su, Karan R. Kathuria, Chih Long Liu, Xiaoman Kang, Maya J. Strohband, Deanna Langfitt, Kristine Faye Pobre-Piza, Sherri Surman, Feng Tian, Valeria Spina, Thomas Tousseyn, Lieselot Buedts, Richard Hoppe, Yasodha Natkunam, Luc-Matthieu Fornecker, Sharon M. Castellino, Ranjana Advani, Davide Rossi, Ryan Lynch, Hervé Ghesquières, Olivier Casasnovas, David M. Kurtz, Lianna J. Marks, Michael P. Link, Marc André, Peter Vandenberghe, Christian Steidl, Maximilian Diehn, Ash A. Alizadeh. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Nature 2024; 625(7996): 778 doi: 10.1038/s41586-023-06903-x
|